SD Biosensor Inc
KRX:137310
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
SD Biosensor Inc
Cash from Operating Activities
SD Biosensor Inc
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
SD Biosensor Inc
KRX:137310
|
Cash from Operating Activities
₩156.5B
|
CAGR 3-Years
-50%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Suheung Co Ltd
KRX:008490
|
Cash from Operating Activities
₩76.9B
|
CAGR 3-Years
13%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Cash from Operating Activities
₩22.3B
|
CAGR 3-Years
19%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Cash from Operating Activities
-₩92.6B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Cash from Operating Activities
₩46.6B
|
CAGR 3-Years
35%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
|
I
|
Interojo Co Ltd
KOSDAQ:119610
|
Cash from Operating Activities
₩25.3B
|
CAGR 3-Years
28%
|
CAGR 5-Years
8%
|
CAGR 10-Years
4%
|
|
SD Biosensor Inc
Glance View
SD Biosensor, Inc. develops and manufactures cholesterol, blood glucose testing and monitoring equipment. The company is headquartered in Suwon, Gyeonggi-Do. The company went IPO on 2021-07-16. The firm is engaged in the immunochemical diagnosis, molecular diagnosis, point-of-care diagnosis (POCTs), and self blood glucose measurement business. The firm is engaged in the research, development and sale of products such as rapid immunochemical diagnosis products, immunochemical fluorescence diagnosis products, molecular diagnosis products, enzyme immunological reaction diagnosis products and others. The firm distributes its products within domestic market and to overseas markets.
See Also
What is SD Biosensor Inc's Cash from Operating Activities?
Cash from Operating Activities
156.5B
KRW
Based on the financial report for Dec 31, 2024, SD Biosensor Inc's Cash from Operating Activities amounts to 156.5B KRW.
What is SD Biosensor Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-50%
The average annual Cash from Operating Activities growth rates for SD Biosensor Inc have been -50% over the past three years .
